DOCSLIB.ORG

Metabolomics and Lipidomics Contributions to Type 1 Diabetes Research F

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Metabolomics and Lipidomics Contributions to Type 1 Diabetes Research F CellR4 2020; 8: e2941 Metabolomics and lipidomics contributions to type 1 diabetes research F. Cesare Marincola Department of Chemical and Geological Sciences, University of Cagliari, University Campus, Monserrato, Cagliari, Italy Corresponding Author: F. Cesare Marincola, PhD; e-mail: [email protected] Keywords: Lipidomics, Metabolomics, Type 1 diabetes, creatic b-cells with consequent insulin deficiency. T1D. Type 2 diabetes (T2D) is the most common form of diabetes (about 90% of cases) and generally occurs ABSTRACT after 30-40 years of age5. T2D is characterized by a Metabolomics is a “omic” science with a focus on progressive loss of adequate b-cell insulin secretion the characterization of metabolome, that is the frequently on the background of insulin resistance. pool of low molecular weight (< 1.5 kDa) metab- Gestational diabetes is one of the most common olites involved in the metabolism of a biological pregnancy complications and usually disappears af- system. When the targets are lipids, metabolomics ter giving birth6. This condition occurs in about 7% is commonly referred to as lipidomics. Since the of pregnancies. The definition is valid regardless of metabolome composition is influenced by several the type of treatment (diet, physical exercise or insu- factors such as environment, disease, drugs, and lin) and the persistence of diabetes even after preg- genetics, metabolomics is extensively used in the nancy. Both World Health Organization (WHO) and biomedical research for the identification of met- American Diabetes Association (ADA) have identi- abolic signatures or novel biomarkers useful in fied an intermediate type of diabetes for individu- diagnosis, prediction, prognosis, and prevention als whose glucose levels do not meet the criteria for of disease. In recent years, both metabolomics diabetes but are too high to be considered normal. and lipidomics have been extensively employed This condition of very high risk of evolving towards in diabetes research to elucidate the molecular the diabetes, especially T2D, is referred to as im- mechanisms triggering this disease and to discov- paired glucose tolerance, also known as pre-diabe- er biomarkers for its prevention, diagnosis, and tes. Finally, there is a form of hybrid diabetes called treatment. In this review, some of the most signifi- “latent autoimmune diabetes in adults” (LADA) that cant findings relative to studies performed on type includes both autoimmune destruction of pancreatic 1 diabetes patients are summarized to provide an b-cells and some degrees of insulin resistance7. Pa- overview of the potential of these approaches. tients with LADA are treated for a short period after diagnosis without insulin injections. Epidemiological data indicate that the number of INTRODUCTION people affected by T1D and T2D is increasing rap- idly worldwide. According to the International Di- The term diabetes mellitus, commonly referred to abetes Federation8, in 2019 approximately 463 mil- as diabetes, is used to define a group of metabolic lion adults (20-79 years) were living with diabetes, disorders characterized by elevated blood glucose and by 2045 this number is estimated to reach 700 levels due to defects in insulin secretion and/or ac- million. More than 1.1 million children and adoles- tion1. Type 1 diabetes (T1D) is an autoimmune dis- cents are living with T1D with the highest incidence ease that represents 5-10% of all cases of diabetes2. in Finland (64.2/100.000)9 followed by the island of It develops at any age but occurs most frequently in Sardinia, Italy (45/100.000)10. These data are further children and adolescents3,4. T1D is characterized by aggravated by the fact that the chronic hyperglyce- a progressive destruction of insulin-producing pan- mia of diabetes is associated with long-term com- This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License 1 2 F. Cesare Marincola plications and comorbidities such as cardiovascular factors such as lifestyle, diet, drug consumption, disease, hypertension, dyslipidemia, diabetic ne- and development of diseases, to name just a few15. phropathy, neuropathy, and retinopathy, becoming The main analytical platforms used in metabolom- one of the top 10 causes of death in adults11. ics are the following: nuclear magnetic resonance The exact etiology of diabetes is unknown. The (NMR) spectroscopy and mass spectrometry (MS) genetic component has an important weight on the combined with gas chromatography (GC-MS), liq- predisposition of diabetes, but it does not have a uid chromatography (LC-MS), high performance direct cause-effect relationship with this disease. liquid chromatography (HPLC-MS), and capillary Indeed, the pathogenetic mechanisms underlying electrophoresis (CE-MS). Basically, NMR offers the clinical phenotype of diabetes are by nature a good reproducibility, is not destructive, and re- complex and arise from a variable interaction be- quires relatively simple and fast preparations of tween genetic and environmental (non-genetic) risk samples. Nevertheless, the low sensitivity of NMR factors. In case of T2D, one of the most significant confines its applications to concentration mea- factors influencing the development of disease is surements in the micromolar to millimolar range. lifestyle, commonly associated with urbanization. MS method is more sensitive than NMR, but it Different studies have established that lifestyle is a destructive technique and requires extensive modification together with physical activity and/or sample preparation, including the derivatization healthy diet can delay or prevent the onset of T2D12. of compounds in case of GC-MS. No one of these Differently, at present, T1D cannot be prevented techniques can provide alone a complete picture yet since the complex molecular network responsi- of metabolome; therefore, a complementary use of ble for the destruction of b-cells is still enigmatic, both technologies is particularly useful to gain a thus slowing down the identification of parameters broader perspective. A detailed description of these with the role of specific T1D indicators13. So, pre- techniques, their advantages and drawbacks are the diction of T1D is done based on the risk assessment subject of various reviews. The reader is referred to defined by a combined use of genetic, immunolog- the literature for further information16-19. ic, and metabolic parameters, while the diagnosis Different types of biofluids can be analyzed in is done when the symptoms are evident. To reduce metabolomics such as blood, urine, faecal extracts the pandemic of T1D and its disastrous social, eco- and saliva. No single biofluid is appropriate for all nomic, and health impacts worldwide, there is an studies; blood20 and urine21 samples can provide sig- urgent need to improve the understanding of the nificant insight into the dysregulation of metabolism molecular network responsible for the destruction at the organ level, while faecal22 and saliva23 metab- of b-cells to identify strategies useful to the pre- olome are specifically informative on microbiota. vention, diagnosis and treatment of this disease. Over the past decades, metabolomics has been successfully applied in medicine and molecular biol- ogy. It has provided useful contributions to the dis- METABOLOmiCS AND LIPIDOmiCS covery of new biochemical pathways in diseases, the understanding of their role in triggering pathologies, Metabolomics is a “omics science” aimed at iden- and the discovery of new therapeutic targets and bio- tifying and quantifying the set of low molecular markers for early diagnosis or monitoring therapeu- weight metabolites (typically < 1500 Da), known tic activities24. More recently, lipidomics, a branch of as metabolome, present in a biological sample metabolomics which studies the complete set of lipids such as biofluids, cells, tissues, and organs14. The (lipidome) produced in a given cell or organism, has metabolome consists of both endogenous and ex- garnered attention, particularly in relation to diseases ogenous components, including amino acids, pep- characterized by dysregulated lipid metabolism. The tides, nucleic acids, organic acids, vitamins, and development of lipidomics has been largely driven by carbohydrates. Since the metabolome composition rapid advances in MS technologies25. can be viewed as a mirror that reflects the glob- Both metabolomics and lipidomics have emerged al assessment of a cellular state, interrogating the as promising approaches also in diabetes research. metabolome enables to investigate the metabolic According to a statistics obtained by searching status of an organism in normal or disruptive phys- “metabolomics, metabolome, lipidomics, or lip- iologic conditions due to altered environmental idome and diabetes” in the “article title, abstract Metabolomics and lipidomics contributions to type 1 diabetes research 3 Figure 1. Research outputs of metabolomics and lipidomics studies in diabetes research. Data were gathered by Scopus26 searching for the terms “metabolomics” or “metabolome” or “lipidomics” or “lipidome” and “diabetes” in “article title, abstract and keywords” field. and keywords” in SCOPUS database26, 2976 con- Within these studies, important contributions to tributions (articles, reviews, books, book chapters, the understanding of T1D pathogenesis have been editorials, notes, and letters) have been published obtained by applying metabolomics and lipidomics since 2002 (Figure 1). Among these, 139 have been
Load more

Recommended publications
  • Expanding the Molecular Landscape of Exercise Biology
    H OH metabolites OH Review Metabolomics and Lipidomics: Expanding the Molecular Landscape of Exercise Biology Mehdi R. Belhaj 1, Nathan G. Lawler 2,3 and Nolan J. Hoffman 1,* 1 Exercise and Nutrition Research Program, Mary MacKillop Institute for Health Research, Australian Catholic University, Melbourne 3000, Australia; [email protected] 2 Australian National Phenome Centre, Health Futures Institute, Murdoch University, Harry Perkins Building, Murdoch, Perth 6150, Australia; [email protected] 3 School of Health and Medical Sciences, Edith Cowan University, Joondalup 6027, Australia * Correspondence: [email protected]; Tel.: +61-3-9230-8277 Abstract: Dynamic changes in circulating and tissue metabolites and lipids occur in response to exercise-induced cellular and whole-body energy demands to maintain metabolic homeostasis. The metabolome and lipidome in a given biological system provides a molecular snapshot of these rapid and complex metabolic perturbations. The application of metabolomics and lipidomics to map the metabolic responses to an acute bout of aerobic/endurance or resistance exercise has dramatically expanded over the past decade thanks to major analytical advancements, with most exercise-related studies to date focused on analyzing human biofluids and tissues. Experimental and analytical considerations, as well as complementary studies using animal model systems, are warranted to help overcome challenges associated with large human interindividual variability and decipher the breadth of molecular mechanisms underlying the metabolic health-promoting effects of exercise. In this review, we provide a guide for exercise researchers regarding analytical techniques and experimental workflows commonly used in metabolomics and lipidomics. Furthermore, we discuss Citation: Belhaj, M.R.; Lawler, N.G.; advancements in human and mammalian exercise research utilizing metabolomic and lipidomic Hoffman, N.J.
    [Show full text]
  • Important Considerations for Sample Collection in Metabolomics Studies with a Special Focus on Applications to Liver Functions
    H OH metabolites OH Review Important Considerations for Sample Collection in Metabolomics Studies with a Special Focus on Applications to Liver Functions Lorraine Smith 1, Joran Villaret-Cazadamont 1, Sandrine P. Claus 2 ,Cécile Canlet 1, Hervé Guillou 1 , Nicolas J. Cabaton 1 and Sandrine Ellero-Simatos 1,* 1 Toxalim (Research Center in Food Toxicology), Université de Toulouse, INRAE, ENVT, INP-Purpan, UPS, 31300 Toulouse, France; [email protected] (L.S.); [email protected] (J.V.-C.); [email protected] (C.C.); [email protected] (H.G.); [email protected] (N.J.C.) 2 LNC Therapeutics, 17 place de la Bourse, 33076 Bordeaux, France; [email protected] * Correspondence: [email protected] Received: 11 February 2020; Accepted: 7 March 2020; Published: 12 March 2020 Abstract: Metabolomics has found numerous applications in the study of liver metabolism in health and disease. Metabolomics studies can be conducted in a variety of biological matrices ranging from easily accessible biofluids such as urine, blood or feces, to organs, tissues or even cells. Sample collection and storage are critical steps for which standard operating procedures must be followed. Inappropriate sample collection or storage can indeed result in high variability, interferences with instrumentation or degradation of metabolites. In this review, we will first highlight important general factors that should be considered when planning sample collection in the study design of metabolomic studies, such as nutritional status and circadian rhythm. Then, we will discuss in more detail the specific procedures that have been described for optimal pre-analytical handling of the most commonly used matrices (urine, blood, feces, tissues and cells).
    [Show full text]
  • S41598-018-25035-1.Pdf
    www.nature.com/scientificreports OPEN An Innovative Approach for The Integration of Proteomics and Metabolomics Data In Severe Received: 23 October 2017 Accepted: 9 April 2018 Septic Shock Patients Stratifed for Published: xx xx xxxx Mortality Alice Cambiaghi1, Ramón Díaz2, Julia Bauzá Martinez2, Antonia Odena2, Laura Brunelli3, Pietro Caironi4,5, Serge Masson3, Giuseppe Baselli1, Giuseppe Ristagno 3, Luciano Gattinoni6, Eliandre de Oliveira2, Roberta Pastorelli3 & Manuela Ferrario 1 In this work, we examined plasma metabolome, proteome and clinical features in patients with severe septic shock enrolled in the multicenter ALBIOS study. The objective was to identify changes in the levels of metabolites involved in septic shock progression and to integrate this information with the variation occurring in proteins and clinical data. Mass spectrometry-based targeted metabolomics and untargeted proteomics allowed us to quantify absolute metabolites concentration and relative proteins abundance. We computed the ratio D7/D1 to take into account their variation from day 1 (D1) to day 7 (D7) after shock diagnosis. Patients were divided into two groups according to 28-day mortality. Three diferent elastic net logistic regression models were built: one on metabolites only, one on metabolites and proteins and one to integrate metabolomics and proteomics data with clinical parameters. Linear discriminant analysis and Partial least squares Discriminant Analysis were also implemented. All the obtained models correctly classifed the observations in the testing set. By looking at the variable importance (VIP) and the selected features, the integration of metabolomics with proteomics data showed the importance of circulating lipids and coagulation cascade in septic shock progression, thus capturing a further layer of biological information complementary to metabolomics information.
    [Show full text]
  • A Metabolomics Approach to Pharmacotherapy Personalization
    Journal of Personalized Medicine Review A Metabolomics Approach to Pharmacotherapy Personalization Elena E. Balashova *, Dmitry L. Maslov and Petr G. Lokhov Institute of Biomedical Chemistry, Pogodinskaya St. 10, Moscow 119121, Russia; [email protected] (D.L.M.); [email protected] (P.G.L.) * Correspondence: [email protected] Received: 29 June 2018; Accepted: 3 September 2018; Published: 5 September 2018 Abstract: The optimization of drug therapy according to the personal characteristics of patients is a perspective direction in modern medicine. One of the possible ways to achieve such personalization is through the application of “omics” technologies, including current, promising metabolomics methods. This review demonstrates that the analysis of pre-dose metabolite biofluid profiles allows clinicians to predict the effectiveness of a selected drug treatment for a given individual. In the review, it is also shown that the monitoring of post-dose metabolite profiles could allow clinicians to evaluate drug efficiency, the reaction of the host to the treatment, and the outcome of the therapy. A comparative description of pharmacotherapy personalization (pharmacogenomics, pharmacoproteomics, and therapeutic drug monitoring) and personalization based on the analysis of metabolite profiles for biofluids (pharmacometabolomics) is also provided. Keywords: pharmacometabolomics; metabolomics; pharmacogenomics; therapeutic drug monitoring; personalized medicine; mass spectrometry 1. Introduction The uniformity of the drug response or low inter-individual differences in drug response are commonly accepted tenets in the field of medicine. Almost all drugs are prescribed on the basis of this statement. This approach can be described as treatment of the “average patient” by “the average pill” or “one size fits all”. However, clinicians have long observed that the actual effectiveness of the pharmacotherapy may be variable.
    [Show full text]
  • The Metabolomic Paradigm of Pharmacogenomics in Complex
    ics: O om pe ol n b A a c t c e e M s s Cacabelos, Metabolomics 2012, 2:5 Metabolomics: Open Access DOI: 10.4172/2153-0769.1000e119 ISSN: 2153-0769 Editorial Open Access The Metabolomic Paradigm of Pharmacogenomics in Complex Disorders Ramón Cacabelos1,2* 1EuroEspes Biomedical Research Center, Institute for CNS Disorders and Genomic Medicine, EuroEspes Chair of Biotechnology and Genomics, 15165-Bergondo, Corunna, Spain 2President, World Association of Genomic Medicine, Spain Metabolomics represents the networking organization of multiple pathogenic genes usually converge in metabolomic networks leading biochemical pathways leading to a physiological function in living to specific pathogenic cascades responsible for disease phenotypes. organisms. The frontier between health and disease is likely to be the The genomics of the mechanism of action of drugs has so far been result of a fine-tuning equilibrium or disequilibrium, respectively, neglected by the scientific community, and consequently less than 5% between the genomic-transcriptomic-proteomic-metabolomic cascade of FDA-approved drugs, with a pharmacologically-defined mechanism and environmental factors and/or epigenetic phenomena. In recent of action, have been studied in order to evaluate whether mutations times, diverse metabolomic studies have emerged in medical science in the genes encoding receptors or enzymes may affect efficacy and to explain physiological and pathogenic events in several disciplines, safety issues. Pleiotropic genes, involved in multiple pathogenic events,
    [Show full text]
  • Model-Based Integration of Genomics and Metabolomics Reveals SNP Functionality in Mycobacterium Tuberculosis
    Model-based integration of genomics and metabolomics reveals SNP functionality in Mycobacterium tuberculosis Ove Øyåsa,b,1, Sonia Borrellc,d,1, Andrej Traunerc,d,1, Michael Zimmermanne, Julia Feldmannc,d, Thomas Liphardta,b, Sebastien Gagneuxc,d, Jörg Stellinga,b, Uwe Sauere, and Mattia Zampierie,2 aDepartment of Biosystems Science and Engineering, ETH Zurich, 4058 Basel, Switzerland; bSIB Swiss Institute of Bioinformatics, 1015 Lausanne, Switzerland; cDepartment of Medical Parasitoloy and Infection Biology, Swiss Tropical and Public Health Institute, 4051 Basel, Switzerland; dUniversity of Basel, 4058 Basel, Switzerland; and eInstitute of Molecular Systems Biology, ETH Zurich, 8093 Zurich, Switzerland Edited by Ralph R. Isberg, Tufts University School of Medicine, Boston, MA, and approved March 2, 2020 (received for review September 12, 2019) Human tuberculosis is caused by members of the Mycobacterium infection of macrophages (29–32). Beyond analyses of individual tuberculosis complex (MTBC) that vary in virulence and transmis- laboratory strains, however, no systematic characterization and sibility. While genome-wide association studies have uncovered comparative analysis of intrinsic metabolic differences across several mutations conferring drug resistance, much less is known human-adapted MTBC clinical strains has been performed. about the factors underlying other bacterial phenotypes. Variation If the metabolic and other phenotypic diversity between in the outcome of tuberculosis infection and diseases has been MTBC strains contributes to and modulates pathogenicity, an attributed primarily to patient and environmental factors, but obvious question is: Which elements of the limited genetic di- recent evidence indicates an additional role for the genetic diver- versity in the MTBC are responsible for phenotypic strain di- sity among MTBC clinical strains.
    [Show full text]
  • M. Tomita T. Nishioka (Eds.) Metabolomics the Frontier of Systems Biology
    M. Tomita T. Nishioka (Eds.) Metabolomics The Frontier of Systems Biology M. Tomita, T. Nishioka (Eds.) Metabolomics The Frontier of Systems Biology With 112 Figures, Including 4 in Color Springer Masaru Tomita, Ph.D. Professor and Director Institute for Advanced Biosciences Keio University Tsuruoka 997-0035, Japan Takaaki Nishioka, Ph.D. Professor Graduate School of Agricuhure Kyoto University Kyoto 606-8502, Japan This book is based on the Japanese original, M. Tomita, T. Nishioka (Eds.), Metabolome Kenkyu no Saizensen, Springer-Verlag Tokyo, 2003. Library of Congress Control Number: 2005928331 ISBN 4-431-25121-9 Springer-Verlag Tokyo Berlin Heidelberg New York This work is subject to copyright. All rights are reserved, whether the whole or part of the material is concerned, specifically the rights of translation, reprinting, reuse of illustrations, recitation, broadcasting, reproduction on microfilms or in other ways, and storage in data banks. The use of registered names, trademarks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant protective laws and regulations and therefore free for general use. Product liability: The publishers cannot guarantee the accuracy of any information about dosage and application contained in this book. In every individual case the user must check such information by consulting the relevant literature. Springer is a part of Springer Science+Business Media springeronline.com © Springer-Vertag Tokyo 2005 Printed in Japan Typesetting: Camera-ready by the editor. Printing and binding: Nikkei Printing, Japan Printed on acid-free paper Preface The aim of this book is to review metabolomics research.
    [Show full text]
  • Lipidomics and Metabolomics Service Gain Deeper Insights Into Exosomes
    EXOSOMES LIPIDOMICS AND METABOLOMICS SERVICE GAIN DEEPER INSIGHTS INTO EXOSOMES SYSTEMBIO.COM/LIPIDOMICS HIGHLIGHTS What can lipidomics of exosomes tell you? n Discover novel circulating biomarkers Lipids are an important part of cellular physiology, and are increasingly being recognized for their importance in exosome biology as well. Exosomes were recently shown to have the highest lipid- n Learn more about exosome biology to-protein ratio of all classes of extracellular vesicles (1), with lipid content that both differs from n Send us your sample and receive data the parent cell the vesicles are shed from (2) and also changes as exosomes undergo a variety of in 4 - 6 weeks physiological processes (3). These unique lipid profiles can serve as novel circulating biomarkers, and recent evidence suggests that specific lipid species carried by exosomes can also modulate Service Overview the function of recipient cells (4). Whether you’re interested in With so much information revealed by lipid content, lipidomics studies of exosomes are a great way to identify lipid-based biomarkers and for understanding vesicle biogenesis and function (5). circulating biomarker discovery, basic exosome research, or other TUMOR MICROENVIRONMENT exosome-related studies, SBI’s CANCER CELLS CAFs EXOSOMES Exosome Lipidomics & Metabolomics Service helps you quickly and efficiently get the most information from your exosomes. Simply send Exosomes affect metabolism of cancer us your sample or purified exosomes cells A recent study by Zhao, et al, (6) and we’ll send back a report with demonstrated that exosomes from putative identifications, mass/charge patient-derived cancer-associated fibroblasts (CAFs) can reprogram EXOSOME ratios, and differential analysis (if UPTAKE the cellular machinery in cancer requested).
    [Show full text]
  • Lipidomics at the Interface of Structure and Function in Systems Biology
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector Chemistry & Biology Crosstalk Lipidomics at the Interface of Structure and Function in Systems Biology Richard W. Gross1,2,3,4,* and Xianlin Han1,2 1Division of Bioorganic Chemistry and Molecular Pharmacology 2Departments of Medicine 3Developmental Biology Washington University School of Medicine, St. Louis, MO 63110, USA 4Department of Chemistry, Washington University, St. Louis, MO 63105, USA *Correspondence: [email protected] DOI 10.1016/j.chembiol.2011.01.014 Cells, tissues, and biological fluids contain a diverse repertoire of many tens of thousands of structurally distinct lipids that play multiple roles in cellular signaling, bioenergetics, and membrane structure and func- tion. In an era where lipid-related disease states predominate, lipidomics has assumed a prominent role in systems biology through its unique ability to directly identify functional alterations in multiple lipid metabolic and signaling networks. The development of shotgun lipidomics has led to the facile accrual of high density information on alterations in the lipidome mediating physiologic cellular adaptation during health and path- ologic alterations during disease. Through both targeted and nontargeted investigations, lipidomics has already revealed the chemical mechanisms underlying many lipid-related disease states. The Multiple Roles of Lipids (Zhang et al., 2002; Breen et al., 2005). Cantley, 2006; Chiang et al., 2006; Simon in Cellular
    [Show full text]
  • IPA Analysis of Metabolomics Data Including Cross-Platform Integration with Transcriptomics Data from a Diabetic Mouse Model
    IPA Analysis of Metabolomics Data Including Cross-Platform Integration with Transcriptomics Data from a Diabetic Mouse Model CONTENTS Overview ........................................................................................................................................................................ 3 Introduction ................................................................................................................................................................... 3 Metabolomics Background ........................................................................................................................................ 3 Integration of Metabolomic and Transcriptomic data .............................................................................................. 5 The Ingenuity Platform .............................................................................................................................................. 5 Case Study Background ............................................................................................................................................. 5 Methods ........................................................................................................................................................................ 6 Establishing a Metabolite profile for db/db mice and identification of exploratory biomarkers .............................. 6 IPA-Metabolomics™ Analysis: ...................................................................................................................................
    [Show full text]
  • Multi-Omics Approaches and Radiation on Lipid Metabolism in Toothed Whales
    life Review Multi-Omics Approaches and Radiation on Lipid Metabolism in Toothed Whales Jayan D. M. Senevirathna 1,2,* and Shuichi Asakawa 1 1 Laboratory of Aquatic Molecular Biology and Biotechnology, Department of Aquatic Bioscience, Graduate School of Agricultural and Life Sciences, The University of Tokyo, Tokyo 113-8657, Japan; [email protected] 2 Department of Animal Science, Faculty of Animal Science and Export Agriculture, Uva Wellassa University, Badulla 90000, Sri Lanka * Correspondence: [email protected] Abstract: Lipid synthesis pathways of toothed whales have evolved since their movement from the terrestrial to marine environment. The synthesis and function of these endogenous lipids and affecting factors are still little understood. In this review, we focused on different omics approaches and techniques to investigate lipid metabolism and radiation impacts on lipids in toothed whales. The selected literature was screened, and capacities, possibilities, and future approaches for identify- ing unusual lipid synthesis pathways by omics were evaluated. Omics approaches were categorized into the four major disciplines: lipidomics, transcriptomics, genomics, and proteomics. Genomics and transcriptomics can together identify genes related to unique lipid synthesis. As lipids interact with proteins in the animal body, lipidomics, and proteomics can correlate by creating lipid-binding proteome maps to elucidate metabolism pathways. In lipidomics studies, recent mass spectroscopic methods can address lipid profiles; however, the determination of structures of lipids are challeng- ing. As an environmental stress, the acoustic radiation has a significant effect on the alteration of Citation: Senevirathna, J.D.M.; Asakawa, S. Multi-Omics Approaches lipid profiles. Radiation studies in different omics approaches revealed the necessity of multi-omics and Radiation on Lipid Metabolism applications.
    [Show full text]
  • Glossary of Terms
    GLOSSARY OF TERMS Table of Contents A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z A Amino acids: any of a class of 20 molecules that are combined to form proteins in living things. The sequence of amino acids in a protein and hence protein function are determined by the genetic code. From http://www.geneticalliance.org.uk/glossary.htm#C • The building blocks of proteins, there are 20 different amino acids. From https://www.yourgenome.org/glossary/amino-acid Antisense: Antisense nucleotides are strings of RNA or DNA that are complementary to "sense" strands of nucleotides. They bind to and inactivate these sense strands. They have been used in research, and may become useful for therapy of certain diseases (See Gene silencing). From http://www.encyclopedia.com/topic/Antisense_DNA.aspx. Antisense and RNA interference are referred as gene knockdown technologies: the transcription of the gene is unaffected; however, gene expression, i.e. protein synthesis (translation), is lost because messenger RNA molecules become unstable or inaccessible. Furthermore, RNA interference is based on naturally occurring phenomenon known as Post-Transcriptional Gene Silencing. From http://www.ncbi.nlm.nih.gov/probe/docs/applsilencing/ B Biobank: A biobank is a large, organised collection of samples, usually human, used for research. Biobanks catalogue and store samples using genetic, clinical, and other characteristics such as age, gender, blood type, and ethnicity. Some samples are also categorised according to environmental factors, such as whether the donor had been exposed to some substance that can affect health.
    [Show full text]